Navigation Links
Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report

TUSTIN, Calif., Jan. 6 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with operations in China and the US, announced today industry analyst Lauren Rudd has issued a strong buy recommendation for AMDL in his year-end financial research report on the Company.

The report projects a 12-month target price of $5.00 for AMDL and highlights the Company's:

    -- Consistent, positive historical financial performance over the past
       four years
    -- Most recent operational changes and business updates, including an
       updated overview of AMDL's China-based subsidiary Jade Pharmaceuticals,
    -- FY2009 product pipeline
    -- FY2009 plans for the AMDL ELISA DR-70(R) (FDP) cancer monitoring test;
       best-selling Human Placenta Extract (HPE) anti-aging product line; and
       MYHPV Chip(R) diagnostic test kit which detects approximately 28
       different strains of the Human Papilloma Virus.

The research report also provides a thorough peer group comparison with valuation analyses, views and opinions on AMDL's projected financial performance for the 2009 fiscal year, and historical financials.

According to Mr. Rudd, "AMDL has taken major initiatives to build its strengths while reorganizing top management and still producing respectable financials which has resulted in AMDL being one of the most under priced stocks we have seen in a long time."

A full copy of the report is available for downloading online at or by contacting Ms. Kristine Szarkowitz, AMDL's Director Investor Relations, at

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

     AMDL Contact:
     Kristine Szarkowitz
     Director-Investor Relations
     (Tel :) 206.310.5323

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
2. Cardium Reports on Exchange Listing With NYSE Alternext US
3. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
4. Joint Commission Reports Positive Survey Results for CHA
5. Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability
6. Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability
7. Risks and Benefits of Egg Donation Reported
8. LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
9. Despite Sagging Economy, Viamedic Reports Solid Online Sales for Erectile Dysfunction Drugs
10. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
11. Published reports inaccurate concerning alcohol consumption during pregnancy
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Doctors who missed a ... to recognize the signs of mesothelioma and push for a diagnosis, especially in people ... website. Click here to read it now. , Researchers at Gifu ...
(Date:11/28/2015)... Diego, California (PRWEB) , ... November 28, 2015 ... ... medical image exchange technology and teleradiology services, has added Chris Hafey and Claude ... to exhibit at the Radiological Society of North America (RSNA) 2015 Annual Meeting ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Pixel Film ... customizable media panels to choose from, the possibilities are endless. Users have full control ... With the ProPanel: Pulse masking effects, users are sure to get heads to turn. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... that they are handling security in light of the recent terrorist attacks in Paris, ... attempt to stop an attack from reaching U.S. soil. Especially around special events that ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
Breaking Medicine Technology: